Emerging Technologies for the Management of Colon Cancer
Emerging Technologies for the Management of Colon Cancer is organized by Horizon CME.
Course opens: 09/08/2023
Course expires: 09/08/2024
Description:
Colon cancer is the 3rd most common cancer in the US and ranks 2nd as the cause of cancer-related deaths overall. Participants will improve their understanding of how tumor profiles and biomarker analysis can assist in selecting targeted therapies for patients with colon cancer. Experts will also discuss the evidence available for circulating tumor DNA assays and they can detect minimal residual disease in colorectal cancer patients.
Learning Objectives:
• Describe how to use tumor profile, biomarker analysis, and patient-specific characteristics to select targeted therapies for individuals with colon cancer
• Review the evidence for use of circulating tumor (ct) DNA assays in detecting minimal residual disease in patients with colorectal cancer
Additional details will be posted as soon as information is available.